Expression of cellular oncogenes in human prostatic carcinoma cell lines

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Prostate cancer is a common malignancy in Western countries.
• Endocrine therapy initially controls prostate tumor growth, but androgen-independent tumors emerge.
• Understanding oncogene expression is crucial for prostate cancer research.

Purpose of the Study:

• To investigate the expression patterns of various oncogenes in different human prostate carcinoma cell lines.
• To compare oncogene expression between androgen-dependent and androgen-independent prostate cancer cells.
• To determine the effect of androgen withdrawal on oncogene expression in hormone-dependent cells.

Main Methods:

• Analysis of oncogene mRNA expression using techniques like Northern blotting or RT-PCR.
• Utilizing four human prostate carcinoma cell lines: PC 3, PC 133, PC 135 (androgen-independent) and PC 82 (hormone-dependent).
• Inducing androgen withdrawal in the PC 82 cell line to observe changes in oncogene expression.

Main Results:

• Ha-ras and myc mRNA were highly expressed in all tested cell lines.
• N-ras, Ki-ras, myb, fos, fms, and sis mRNA were detected in some cell lines.
• PC 82 cells exhibited high fos expression, which decreased tenfold upon androgen withdrawal; Ha-ras decreased twofold, while myc expression remained unchanged.

Conclusions:

• Oncogene expression profiles differ between androgen-dependent and independent prostate cancer cells.
• Fos expression is significantly regulated by androgens in hormone-dependent prostate cancer.
• These findings contribute to understanding the molecular mechanisms underlying prostate cancer progression and androgen independence.